imipramine has been researched along with Kussmaul Aphasia in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Nissen, G | 1 |
| Spilimbergo, A | 1 |
1 review available for imipramine and Kussmaul Aphasia
| Article | Year |
|---|---|
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
1 other study available for imipramine and Kussmaul Aphasia
| Article | Year |
|---|---|
[On the symptoms and therapy of depressive diseases diagnosed in early childhood].
Topics: Aggression; Body Weight; Child Behavior Disorders; Child, Preschool; Depression; Electroencephalogra | 1970 |